PRECISION OPTIMIZATION OF RADIOTHERAPY PLANNING FOR HEAD AND NECK TUMORS BASED ON THE INTEGRATION OF MULTIPARAMETRIC IMAGING DATA
Keywords:
head and neck tumors, IMRT, VMAT, PET/CT, target delineation, CTV–PTV margin, geometric uncertainty, radiation toxicity, precision radiotherapyAbstract
The aim of the study was to evaluate the clinical effectiveness and safety of multimodal radiotherapy planning for head and neck tumors through the integration of CT, MRI, and PET/CT imaging data. A prospective-retrospective comparative analysis included 22 patients treated with radical IMRT/VMAT (66–70 Gy). Two imaging protocols were compared: CT + MRI (n=15) and CT + MRI + PET/CT (n=7).
The integration of PET/CT reduced the systematic error (Σ) from 3.2 to 1.8 mm and the random error (σ) from 2.1 to 1.2 mm, resulting in a 43% reduction of the calculated CTV–PTV margin (from 9.3 to 5.4 mm). The high-dose volume (70 Gy) decreased by 28% (p<0.05), with significant dose reduction to the brainstem and spinal cord. No increase in severe radiation toxicity was observed. A significant correlation was found between the PTV 66–70 Gy volume and dysphagia (r=0.42; p<0.05), and a threshold relationship was identified between xerostomia and parotid mean dose >26 Gy.
Multimodal imaging-based planning with mathematically justified margin individualization enhances precision in radiotherapy and reduces toxicity without compromising oncological control.
References
Eisbruch A, Ten Haken RK, Kim HM, Marsh LH, Ship JA. Dose, volume, and function relationships in parotid salivary glands following conformal and intensity-modulated irradiation of head and neck cancer. International Journal of Radiation Oncology, Biology, Physics. 1999;45(3):577–587.
Grégoire V, Ang K, Budach W, Grau C, Hamoir M, Langendijk JA, Lee A, Le Q-T, Maingon P, Nutting C, O’Sullivan B, Porceddu SV, Rischin D, Rivera F, Trotti A. Delineation of the neck node levels for head and neck tumors: A 2013 update. Radiotherapy and Oncology. 2014;110(1):172–181.
International Commission on Radiation Units and Measurements (ICRU). Prescribing, Recording, and Reporting Photon-Beam Intensity-Modulated Radiation Therapy (IMRT). ICRU Report 83. Bethesda, MD: ICRU; 2010.
Leemans CR, Snijders PJF, Brakenhoff RH. The molecular landscape of head and neck cancer. Nature Reviews Cancer. 2018;18(5):269–282.
MacManus M, Nestle U, Rosenzweig KE, Carrio I, Messa C, Belohlavek O, et al. Use of PET and PET/CT for radiation therapy planning: IAEA expert report 2006–2007. Radiotherapy and Oncology. 2009;91(1):85–94.
Ng SH, Chan SC, Yen TC, Chang JT, Ko SF, Wang HM, et al. Comprehensive imaging of head and neck cancer: Comparison of MRI, CT, and 18F-FDG PET/CT for nodal staging. Journal of Nuclear Medicine. 2010;51(2).
Paulino AC, Koshy M, Howell R, Schuster D, Davis LW. Comparison of CT- and FDG-PET-defined gross tumor volume in intensity-modulated radiotherapy for head-and-neck cancer. International Journal of Radiation Oncology, Biology, Physics. 2005;61(5):1385–1392.
Pignon JP, le Maître A, Maillard E, Bourhis J; MACH-NC Collaborative Group. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 93 randomised trials and 17,346 patients. Radiotherapy and Oncology. 2009;92(1):4–14.
Schwartz DL, Ford EC, Rajendran J, Yueh B, Coltrera MD, Virgin J, et al. FDG-PET/CT-guided intensity-modulated head and neck radiotherapy: A pilot investigation. International Journal of Radiation Oncology, Biology, Physics. 2005.
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians. 2021;71(3):209–249.
van Herk M. Errors and margins in radiotherapy. Seminars in Radiation Oncology. 2004;14(1):52–64.